Americans cannot absorb billions in added drug price hikes as a result of ill-designed and poorly timed tariff increases.

West Pharmaceutical Services WST is scheduled to release second-quarter 2025 results on July 24, before the opening bell. In ...

West Pharmaceutical Services Inc. (NYSE: WST) is one of the most oversold S&P 500 stocks so far in 2025. On June 24, Barclays ...

“For private equity, the animal health industry is a sweet spot to be in,” said Wille. “You have a growing and attractive ...

PCI Pharma Services, the Northeast Philadelphia-based contract development and manufacturing company has received a ...

Only 39 people have received compensation from the federal program for COVID-19 vaccine injuries. It has rejected another ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the appointment of Robert McMahon ...

Shares of West Pharmaceutical Services Inc. WST slipped 4.83% to $210.89 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.01 ...

The high cost of pharmaceutical products coupled with a lack of federally funded HIV programs create barriers for preexposure ...

Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support ...

Thermo Fisher Scientific Inc. has expanded its strategic partnership with Sanofi to enable additional U.S. drug product ...